According to the data of SFDA, there are 67 enterprises that have qualified for Internet drug trading services so far, of which 36 are B2C models providing drugs to individual consumers, and 23 are B2B models for drug transactions with other companies. There are 8 service platform models. The B2B and B2C of medical e-commerce are different from traditional wholesale and retail, their business concepts and business operations are more efficient, and information flow, business flow, capital flow, logistics and other “four flows†are integrated, electronic and networked. The demand for logistics and distribution is even higher.
However, the logistics and distribution system of China's pharmaceutical e-commerce is in the early stage of construction and development, and faces many challenges. The specific manifestations are as follows:
1. Policy restrictions: According to the Provisional Regulations on the Examination and Approval of Internet Drug Trading Services, only those enterprises that possess both the Internet Drug Service Qualification Certificate and the Internet Drug Information Service Qualification Certificate can carry out online drug sales.
2, logistics and distribution is different from the entire distribution of medical institutions, its delivery orders more, single order purchase volume is smaller, the distribution of customers is more scattered, which requires the logistics distribution center or distribution station must be able to support The minimum packaging medicines can be removed, sorted, reviewed, exported, and distributed with high efficiency. The level of unpacking and sorting of the whole package will determine the accuracy and efficiency of logistics distribution.
3, need to have GSP certification qualification, with the improvement of national GSP standards, hardware and software requirements are higher. Pharmaceutical e-commerce companies usually do not have this qualification, nor do they have a logistics center that they support. They need to cooperate with GSP-compliant pharmaceutical logistics companies that have advanced logistics technologies and equipment.
4. The “last mile†is the key to medical e-commerce. Therefore, it is necessary to establish corresponding distribution outlets, provide professional medical distribution personnel, conduct point-to-point distribution, and provide pharmaceutical services.
5, through the network to achieve sales, information, electronic requirements are higher, we must ensure the integrity of the entire record of the sales process and real-time. Consumers often lack trust in online shopping. Especially for products that are related to good health, people are more willing to obtain them in hospitals and pharmacies.
6. In accordance with the requirements of the GSP, drug sales agencies must be equipped with professional (practitioner) pharmacists to provide professional consultations and deal with various complex problems in drug use. Because online sales are difficult to achieve face-to-face communication, drug disputes have emerged.
According to relevant data, in 2010, the scale of online drug sales in the United States was close to 170 billion U.S. dollars, accounting for nearly 30% of the entire pharmaceutical retail market. The annual turnover of the largest online pharmacy CVS exceeded 15 billion U.S. dollars. In contrast, last year, the pharmaceutical retail market in China was approximately 179.3 billion yuan, and the sales of drugs on the Internet was negligible, with a ratio of less than 1%. As the nation's largest pharmaceutical e-commerce seller, Kyushutong's sales in B2B also exceeded 10. Billion.
E-commerce in medicine bred tremendous vitality. The author believes that breakthroughs can be made from the following aspects:
1. The state loosens its policy and promotes the development of pharmaceutical e-commerce. For example, to establish an industry development plan for pharmaceutical e-commerce, to expand the number of approvals for e-commerce transaction services for pharmaceuticals, to liberalize the sales of prescription drugs, and implement the same management as physical stores.
2. As pharmaceutical e-commerce is in an emerging period of development, many pharmaceutical companies have not yet adopted it as a development direction. The state may wish to give policy support and tilt to advanced companies that conduct pharmaceutical e-commerce.
3. Strengthen the supervision of the whole process of network drug sales, severely crack down on the sales methods of unlicensed operations, illegal operations, and non-drug safety guarantees, strictly supervise network drug promotion, and strictly prevent fraudulent use of the Internet to consumers, increasing public credibility.
4. Encourage pharmaceutical companies and Internet companies to effectively integrate resources and complement and share their advantages. The cooperation between Kyushu Link and Jingdong Mall is an example.
5. Establish logistics management specifications for online sales including procurement, warehousing, unpacking, sorting, delivery, and distribution to ensure that the entire process complies with GSP requirements and ensures the safety of drugs.
6. Combine the characteristics of the network, reconstruct the pharmaceutical supply chain, and explore new sales models.
However, the logistics and distribution system of China's pharmaceutical e-commerce is in the early stage of construction and development, and faces many challenges. The specific manifestations are as follows:
1. Policy restrictions: According to the Provisional Regulations on the Examination and Approval of Internet Drug Trading Services, only those enterprises that possess both the Internet Drug Service Qualification Certificate and the Internet Drug Information Service Qualification Certificate can carry out online drug sales.
2, logistics and distribution is different from the entire distribution of medical institutions, its delivery orders more, single order purchase volume is smaller, the distribution of customers is more scattered, which requires the logistics distribution center or distribution station must be able to support The minimum packaging medicines can be removed, sorted, reviewed, exported, and distributed with high efficiency. The level of unpacking and sorting of the whole package will determine the accuracy and efficiency of logistics distribution.
3, need to have GSP certification qualification, with the improvement of national GSP standards, hardware and software requirements are higher. Pharmaceutical e-commerce companies usually do not have this qualification, nor do they have a logistics center that they support. They need to cooperate with GSP-compliant pharmaceutical logistics companies that have advanced logistics technologies and equipment.
4. The “last mile†is the key to medical e-commerce. Therefore, it is necessary to establish corresponding distribution outlets, provide professional medical distribution personnel, conduct point-to-point distribution, and provide pharmaceutical services.
5, through the network to achieve sales, information, electronic requirements are higher, we must ensure the integrity of the entire record of the sales process and real-time. Consumers often lack trust in online shopping. Especially for products that are related to good health, people are more willing to obtain them in hospitals and pharmacies.
6. In accordance with the requirements of the GSP, drug sales agencies must be equipped with professional (practitioner) pharmacists to provide professional consultations and deal with various complex problems in drug use. Because online sales are difficult to achieve face-to-face communication, drug disputes have emerged.
According to relevant data, in 2010, the scale of online drug sales in the United States was close to 170 billion U.S. dollars, accounting for nearly 30% of the entire pharmaceutical retail market. The annual turnover of the largest online pharmacy CVS exceeded 15 billion U.S. dollars. In contrast, last year, the pharmaceutical retail market in China was approximately 179.3 billion yuan, and the sales of drugs on the Internet was negligible, with a ratio of less than 1%. As the nation's largest pharmaceutical e-commerce seller, Kyushutong's sales in B2B also exceeded 10. Billion.
E-commerce in medicine bred tremendous vitality. The author believes that breakthroughs can be made from the following aspects:
1. The state loosens its policy and promotes the development of pharmaceutical e-commerce. For example, to establish an industry development plan for pharmaceutical e-commerce, to expand the number of approvals for e-commerce transaction services for pharmaceuticals, to liberalize the sales of prescription drugs, and implement the same management as physical stores.
2. As pharmaceutical e-commerce is in an emerging period of development, many pharmaceutical companies have not yet adopted it as a development direction. The state may wish to give policy support and tilt to advanced companies that conduct pharmaceutical e-commerce.
3. Strengthen the supervision of the whole process of network drug sales, severely crack down on the sales methods of unlicensed operations, illegal operations, and non-drug safety guarantees, strictly supervise network drug promotion, and strictly prevent fraudulent use of the Internet to consumers, increasing public credibility.
4. Encourage pharmaceutical companies and Internet companies to effectively integrate resources and complement and share their advantages. The cooperation between Kyushu Link and Jingdong Mall is an example.
5. Establish logistics management specifications for online sales including procurement, warehousing, unpacking, sorting, delivery, and distribution to ensure that the entire process complies with GSP requirements and ensures the safety of drugs.
6. Combine the characteristics of the network, reconstruct the pharmaceutical supply chain, and explore new sales models.
Daoming Optics & Chemical Co., Ltd , https://www.reflectives.nl